Co-Authors
This is a "connection" page, showing publications co-authored by Nathan Grubaugh and Chaney Kalinich.
Connection Strength
1.602
-
Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2. PLoS Biol. 2021 05; 19(5):e3001236.
Score: 0.236
-
Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States. Cell. 2021 05 13; 184(10):2595-2604.e13.
Score: 0.234
-
SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity. Med (N Y). 2021 Mar 12; 2(3):263-280.e6.
Score: 0.230
-
Real-time public health communication of local SARS-CoV-2 genomic epidemiology. PLoS Biol. 2020 08; 18(8):e3000869.
Score: 0.225
-
Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR primer-probe sets. Nat Microbiol. 2020 10; 5(10):1299-1305.
Score: 0.223
-
Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States. Cell. 2020 05 28; 181(5):990-996.e5.
Score: 0.220
-
Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies. PLoS Biol. 2021 07; 19(7):e3001333.
Score: 0.060
-
Diverse functional autoantibodies in patients with COVID-19. Nature. 2021 07; 595(7866):283-288.
Score: 0.059
-
Stability of SARS-CoV-2 RNA in Nonsupplemented Saliva. Emerg Infect Dis. 2021 04; 27(4):1146-1150.
Score: 0.059
-
Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2. N Engl J Med. 2020 09 24; 383(13):1283-1286.
Score: 0.056